Redeye updates on Nitro Games after Q3-results which came in above our expectations owing to solid p...
Redeye has revised its estimates following Heliospectra’s Q3 2025 report.
Beijer Alma levererar en mycket stark rapport för det tredje kvartalet som visar på både en hög orga...
Eastnine levererar för det tredje kvartalet en stark rapport med rekordresultat.
Solteq will report Q3 results this Wednesday, October 29.
Although Consti posted good growth figures in Q3 considering market conditions, margins were lower t...
Fable Media has announced that the refinancing of its outstanding bond will also remove the previous...
Redeye comments on the disappointing news that Guard Therapeutics' drug candidate RMC-035 did not me...
Redeye provides an updated view of Stille following the Q3 2025 report.
Redeye updates its estimates and valuation after Lagercrantz’s Q2 2025/2026 report.
Redeye argues that the negative YTD share price performance does not reflect Xvivo’s underlying fund...
Redeye is making some downward adjustments to our estimates and valuation, following the Q3 report a...
* Q3: -3% org. sales growth, 0% adj. EBITA growth, weak cash flow '25e-'27e adj.
A trade war between the US and India created headwind for Incap's operations in Q3.
The share price has come up by 82% since June 2025.
Redeye has updated its estimates and valuation for Sleep Cycle following the Q3 2025 report, which s...
Redeye retains its positive view of CombinedX following a solid Q3, showing increasing margins due t...
Redeye retains its positive view of Avensia despite slightly lowering our Base Case and forecasts.
* A minor miss compared to FactSet consensus expectations * Small signs of improvement, with a flatt...
* External headwinds delay earnings recovery until 2026e * '25e-'27e EBIT down 27-3%; 18% EBIT CAGR ...